Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.98 USD | +2.05% |
|
-5.68% | -64.28% |
06-28 | Verve Therapeutics, Inc. Announces Board Appointments | CI |
06-10 | Transcript : Verve Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.28% | 410M | |
+16.59% | 45.51B | |
-9.89% | 38.52B | |
+38.08% | 38.13B | |
+27.12% | 30.74B | |
-8.64% | 26.03B | |
+11.81% | 25.92B | |
+45.08% | 14.13B | |
+32.85% | 12.73B | |
-7.19% | 11.29B |
- Stock Market
- Equities
- VERV Stock
- News Verve Therapeutics, Inc.
- Cantor Fitzgerald Initiates Verve Therapeutics at Neutral With $21 Price Target